The actin-binding protein drebrin disrupts NF2-LATS kinases complex assembly to facilitate liver tumorigenesis

Yang Sun1, Henan Wei2, Wentao Yu2

  • 1Sheng Yushou Center of Cell Biology and Immunology, Department of Genetics and Developmental Science, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Minghang, Shanghai, China.

Hepatology (Baltimore, Md.)
|September 26, 2024
PubMed
Abstract

Insights

Drebrin (DBN1) disrupts Hippo signaling by interacting with Neurofibromin 2 (NF2), inhibiting tumor growth. Inhibiting DBN1 shows promise for cancer therapy by restoring NF2 function.

Area of Science:

  • Cell biology
  • Molecular oncology
  • Signal transduction

Background:

  • The Hippo signaling pathway is vital for maintaining tissue homeostasis and is implicated in cancer development.
  • Neurofibromin 2 (NF2) is a key component of Hippo signaling and is linked to human cancers, yet it remains an under-explored therapeutic target.
  • Understanding novel regulators of Hippo signaling is crucial for developing effective cancer treatments.

Purpose of the Study:

  • To identify novel modulators of Hippo signaling pathway components, specifically focusing on Neurofibromin 2 (NF2).
  • To investigate the role of Drebrin (DBN1) in regulating YAP localization and its interaction with NF2.
  • To explore the therapeutic potential of targeting the DBN1-NF2 interaction in cancer, particularly hepatocellular carcinoma (HCC).

Main Methods:

  • Genome-wide RNA interference screen to identify modulators of YAP localization.
  • Biochemical assays to confirm DBN1 interaction with NF2 and its effect on LATS kinase activation.
  • In vitro and in vivo studies using DBN1 mutants and a DBN1 inhibitor (BTP2) to assess effects on tumorigenesis.
  • Combination therapy studies with sorafenib and BTP2 in HCC models.

Main Results:

  • Drebrin (DBN1) was identified as a novel regulator of YAP localization, directly interacting with NF2.
  • DBN1 binding disrupts NF2 interaction with LATS kinases, leading to YAP activation and promoting liver tumorigenesis.
  • A DBN1 mutant (DBN1-3K mut) defective in NF2 binding inhibited YAP activation and tumorigenesis.
  • Pharmacological inhibition of DBN1 with BTP2 restored NF2-LATS binding and demonstrated antitumor activity, synergizing with sorafenib in HCC.

Conclusions:

  • A novel DBN1-NF2-LATS signaling axis regulating Hippo pathway activity in cancer was identified.
  • Pharmacological inhibition of DBN1 represents a promising therapeutic strategy targeting the Hippo pathway for cancer treatment.
  • Targeting DBN1 offers a new avenue for intervention in cancers driven by dysregulated Hippo signaling.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.4K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.6K
Generation of Straight or Branched Actin Filaments01:14

Generation of Straight or Branched Actin Filaments

The straight or branched structure formation of actin filaments is controlled by nucleating proteins such as the formins and Arp2/3 complex. Formin-mediated assembly results in straight filaments, whereas Arp2/3 protein complex-mediated assembly results in branched actin filaments.
Arp2/3 Complex
Arp2/3 complex is a seven-subunit complex consisting of two proteins similar to actin- Arp2 and Arp3, and five other subunits that help keep Arp2 and Arp3 inactive. When required, the complex is...
2.9K
Actin Filament Depolymerization01:19

Actin Filament Depolymerization

Actin filaments (F-actin) are composed of actin subunits. The dissociation of actin monomers can occur from either end of F-actin. The rate of dissociation is faster from the minus-end or the pointed end, where the actin subunits exist with a bound ADP, together known as ADP-actin. The depolymerization of F-actin is aided by proteins, including the actin-depolymerizing factor (ADF) and cofilin family of proteins, gelsolin, and glia maturation factor (GMF).
In F-actin, the ADF/cofilin proteins...
3.1K